FDA Removes Tracking Of Operator Errors From Process Validation Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA and Pfizer successfully lobbied to have the recommendation taken out of the final guidance, calling it "too prescriptive."